HIST1H4A (Ab-79) Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to HIST1H4A (Ab-79) Antibody

HIST1H4A (Ab-79) Antibody is a polyclonal antibody raised in rabbits against a specific peptide sequence surrounding the lysine 79 site of human Histone H4. Histone H4 is a core component of nucleosomes, which are fundamental units of chromatin structure that wrap and compact DNA. The antibody specifically recognizes the region around position 79, which can undergo post-translational modifications such as acetylation that play crucial roles in epigenetic regulation .

The target of this antibody, Histone H4, is encoded by several genes including HIST1H4A, HIST1H4B, HIST1H4C, and others, reflecting the high conservation and importance of histones in cellular function. The antibody's specificity for the lysine 79 position makes it particularly valuable for studying specific epigenetic marks at this location .

Applications in Research

HIST1H4A (Ab-79) Antibody has been validated for multiple research applications, making it a versatile tool in epigenetics and chromatin research. The antibody performs effectively across various techniques commonly used in molecular biology and cell biology research.

Western Blotting

The antibody has been validated for Western blotting with a recommended dilution range of 1:500-1:5000. It has successfully detected Histone H4 in various cell lysates including 293, NIH/3T3, K562, and A549 cell lines, as well as mouse kidney tissue . This application allows researchers to quantify Histone H4 protein levels and study its post-translational modifications in various experimental conditions.

Immunohistochemistry

For immunohistochemistry applications, particularly in paraffin-embedded tissues (IHC-P), the recommended dilution range is 1:1-1:10 . The antibody has been successfully used to detect Histone H4 in human liver cancer tissue, demonstrating its utility in studying histone modifications in pathological conditions .

ELISA

The antibody has been validated for ELISA applications, providing researchers with a tool for quantitative measurement of Histone H4 and its modifications in complex biological samples . This application is particularly useful for high-throughput screening and quantitative analysis of histone modifications.

Chromatin Immunoprecipitation

Select variants of the HIST1H4A (Ab-79) Antibody have been validated for Chromatin Immunoprecipitation (ChIP) assays . This application is crucial for studying histone-DNA interactions and mapping histone modifications across the genome, providing insights into epigenetic regulation of gene expression.

Immunofluorescence and Immunocytochemistry

The antibody has also been validated for immunofluorescence (IF) and immunocytochemistry (ICC) applications with recommended dilutions of 1:1-1:10 for IF and 1:10-1:100 for ICC . These techniques allow visualization of Histone H4 and its modifications within cellular contexts, providing spatial information about histone distribution and modification patterns.

Buffer Composition

The antibody is typically supplied in a specialized buffer designed to maintain stability and activity:

  • Preservative: 0.03% Proclin 300

  • Constituents: 50% Glycerol

  • Buffer: 0.01M PBS, pH 7.4

This formulation helps maintain antibody stability and prevents microbial contamination during storage.

Research Findings and Applications

HIST1H4A (Ab-79) Antibody has proven particularly valuable in epigenetics and nuclear signaling research. Histone H4 is a core component of nucleosomes that wrap and compact DNA, and modifications at the lysine 79 position are associated with specific regulatory functions in gene expression .

The antibody has been used to investigate:

  1. Histone modifications in cancer tissues, as evidenced by its application in human liver cancer tissue studies

  2. Epigenetic regulation in various cell lines including 293, NIH/3T3, K562, and A549

  3. Chromatin structure and function through ChIP experiments that map histone modifications across the genome

  4. Post-translational modifications, particularly acetylation at lysine 79, which is associated with active gene transcription

Research using this antibody contributes to the broader understanding of epigenetic mechanisms that regulate gene expression, development, and disease progression.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we can ship your order within 1-3 business days of receiving it. Delivery times may vary depending on the purchasing method or location. Please consult your local distributor for specific delivery information.
Synonyms
dJ160A22.1 antibody; dJ160A22.2 antibody; dJ221C16.1 antibody; dJ221C16.9 antibody; FO108 antibody; H4 antibody; H4.k antibody; H4/a antibody; H4/b antibody; H4/c antibody; H4/d antibody; H4/e antibody; H4/g antibody; H4/h antibody; H4/I antibody; H4/j antibody; H4/k antibody; H4/m antibody; H4/n antibody; H4/p antibody; H4_HUMAN antibody; H4F2 antibody; H4F2iii antibody; H4F2iv antibody; H4FA antibody; H4FB antibody; H4FC antibody; H4FD antibody; H4FE antibody; H4FG antibody; H4FH antibody; H4FI antibody; H4FJ antibody; H4FK antibody; H4FM antibody; H4FN antibody; H4M antibody; HIST1H4A antibody; HIST1H4B antibody; HIST1H4C antibody; HIST1H4D antibody; HIST1H4E antibody; HIST1H4F antibody; HIST1H4H antibody; HIST1H4I antibody; HIST1H4J antibody; HIST1H4K antibody; HIST1H4L antibody; HIST2H4 antibody; HIST2H4A antibody; Hist4h4 antibody; Histone 1 H4a antibody; Histone 1 H4b antibody; Histone 1 H4c antibody; Histone 1 H4d antibody; Histone 1 H4e antibody; Histone 1 H4f antibody; Histone 1 H4h antibody; Histone 1 H4i antibody; Histone 1 H4j antibody; Histone 1 H4k antibody; Histone 1 H4l antibody; Histone 2 H4a antibody; histone 4 H4 antibody; Histone H4 antibody; MGC24116 antibody
Target Names
HIST1H4A
Uniprot No.

Target Background

Function
Histone H4 is a core component of the nucleosome, the fundamental unit of chromatin. Nucleosomes wrap and compact DNA, restricting accessibility to cellular machinery that requires DNA as a template. Consequently, histones play a critical role in regulating transcription, DNA repair, DNA replication, and maintaining chromosomal stability. DNA accessibility is regulated through a complex set of post-translational modifications of histones, often referred to as the 'histone code,' and nucleosome remodeling.
Gene References Into Functions
  1. Research indicates that PP32 and SET/TAF-Ibeta proteins inhibit HAT1-mediated H4 acetylation. PMID: 28977641
  2. Data suggest that post-translational modifications of histones, specifically trimethylation of lysine 36 in H3 (H3K36me3) and acetylation of lysine 16 in H4 (H4K16ac), are involved in DNA damage repair. H3K36me3 stimulates H4K16ac upon DNA double-strand break. SETD2, LEDGF, and KAT5 are essential for these epigenetic changes. (SETD2 = SET domain containing 2; LEDGF = lens epithelium-derived growth factor; KAT5 = lysine acetyltransferase 5) PMID: 28546430
  3. Studies have shown that Omomyc protein co-localizes with proto-oncogene protein c-myc (c-Myc), protein arginine methyltransferase 5 (PRMT5), and histone H4 H4R3me2s-enriched chromatin domains. PMID: 26563484
  4. H4K12ac is regulated by estrogen receptor-alpha and is associated with BRD4 function and inducible transcription. PMID: 25788266
  5. Systemic lupus erythematosus appears to be associated with an imbalance in histone acetyltransferases and histone deacetylase enzymes, favoring pathological H4 acetylation. PMID: 25611806
  6. Sumoylated human histone H4 prevents chromatin compaction by inhibiting long-range internucleosomal interactions. PMID: 25294883
  7. Acetylation at lysine 5 of histone H4 is associated with lytic gene promoters during reactivation of Kaposi's sarcoma-associated herpesvirus. PMID: 25283865
  8. An increase in histone H4 acetylation caused by hypoxia in human neuroblastoma cell lines corresponds to increased levels of N-myc transcription factor in these cells. PMID: 24481548
  9. Research suggests that G1-phase histone assembly is restricted to CENP-A and H4. PMID: 23363600
  10. This study focused on the distribution of a specific histone modification, namely H4K12ac, in human sperm and characterized its specific enrichment sites in promoters throughout the whole human genome. PMID: 22894908
  11. SRP68/72 heterodimers are major nuclear proteins whose binding of histone H4 tail is inhibited by H4R3 methylation. PMID: 23048028
  12. TNF-alpha inhibition of AQP5 expression in human salivary gland acinar cells is due to the epigenetic mechanism by suppression of acetylation of histone H4. PMID: 21973049
  13. Our data suggest that global histone H3 and H4 modification patterns are potential markers of tumor recurrence and disease-free survival in non-small cell lung cancer. PMID: 22360506
  14. HAT1 differentially impacts nucleosome assembly of H3.1-H4 and H3.3-H4. PMID: 22228774
  15. Phosphorylation of histone H4 Ser 47 catalyzed by the PAK2 kinase, promotes nucleosome assembly of H3.3-H4 and inhibits nucleosome assembly of H3.1-H4 by increasing the binding affinity of HIRA to H3.3-H4 and reducing association of CAF-1 with H3.1-H4. PMID: 21724829
  16. The imatinib-induced hemoglobinization and erythroid differentiation in K562 cells are associated with global histone H4. PMID: 20949922
  17. Our findings reveal the molecular mechanisms whereby the DNA sequences within specific gene bodies are sufficient to nucleate the monomethylation of histone H4 lysine 200 which, in turn, reduces gene expression by half. PMID: 20512922
  18. Downregulated by zinc and upregulated by docosahexaenoate in a neuroblastoma cell line. PMID: 19747413
  19. Low levels of histone acetylation are associated with the development and progression of gastric carcinomas, possibly through alteration of gene expression. PMID: 12385581
  20. Overexpression of MTA1 protein and acetylation level of histone H4 protein are closely related. PMID: 15095300
  21. Peptidylarginine deiminase 4 regulates histone Arg methylation by converting methyl-Arg to citrulline and releasing methylamine; data suggest that PAD4 mediates gene expression by regulating Arg methylation and citrullination in histones. PMID: 15345777
  22. Lack of biotinylation of K12 in histone H4 is an early signaling event in response to double-strand breaks. PMID: 16177192
  23. Incorporation of acetylated histone H4-K16 into nucleosomal arrays inhibits the formation of compact 30-nanometer-like fibers and impedes the ability of chromatin to form cross-fiber interactions. PMID: 16469925
  24. Apoptosis is associated with global DNA hypomethylation and histone deacetylation events in leukemia cells. PMID: 16531610
  25. BTG2 contributes to retinoic acid activity by favoring differentiation through a gene-specific modification of histone H4 arginine methylation and acetylation levels. PMID: 16782888
  26. Relationship between histone H4 modification, epigenetic regulation of BDNF gene expression, and long-term memory for extinction of conditioned fear. PMID: 17522015
  27. The H4 tail and its acetylation have novel roles in mediating recruitment of multiple regulatory factors that can change chromatin states for transcription regulation. PMID: 17548343
  28. Brd2 bromodomain 2 is monomeric in solution and dynamically interacts with H4-AcK12; additional secondary elements in the long ZA loop may be a common characteristic of BET bromodomains. PMID: 17848202
  29. Spermatids Hypac-H4 impairment in mixed atrophy did not deteriorate further by AZFc region deletion. PMID: 18001726
  30. The SET8 and PCNA interaction couples H4-K20 methylation with DNA replication. PMID: 18319261
  31. H4K20 monomethylation and PR-SET7 are important for L3MBTL1 function. PMID: 18408754
  32. High expression of acetylated H4 is more common in aggressive than indolent cutaneous T-cell lymphoma. PMID: 18671804
  33. Our findings indicate an important role of histone H4 modifications in bronchial carcinogenesis. PMID: 18974389
  34. Results indicate, by acetylation of histone H4 K16 during S-phase, early replicating chromatin domains acquire the H4K16ac-K20me2 epigenetic label that persists on the chromatin throughout mitosis & is deacetylated in early G1-phase of the next cell cycle. PMID: 19348949
  35. Acetylated H4 is overexpressed in diffuse large B-cell lymphoma and peripheral T-cell lymphoma relative to normal lymphoid tissue. PMID: 19438744
  36. The release of histone H4 by holocrine secretion from the sebaceous gland may play an important role in innate immunity. PMID: 19536143
  37. Histone modification, including PRC2-mediated repressive histone marker H3K27me3 and active histone marker acH4, may be involved in CD11b transcription during HL-60 leukemia cells reprogramming to terminal differentiation. PMID: 19578722
  38. A role of Cdk7 in regulating elongation is further suggested by enhanced histone H4 acetylation and diminished histone H4 trimethylation on lysine 36 – two marks of elongation – within genes when the kinase was inhibited. PMID: 19667075
  39. Data showed the dynamic fluctuation of histone H4 acetylation levels during mitosis, as well as acetylation changes in response to structurally distinct histone deacetylase inhibitors. PMID: 19805290
  40. Data directly implicate BBAP in the monoubiquitylation and additional posttranslational modification of histone H4 and an associated DNA damage response. PMID: 19818714

Show More

Hide All

Database Links

HGNC: 4781

OMIM: 142750

KEGG: hsa:121504

STRING: 9606.ENSP00000367034

UniGene: Hs.143080

Involvement In Disease
Chromosomal aberrations involving HISTONE H4 is a cause of B-cell non-Hodgkin lymphomas (B-cell NHL). Translocation t(3;6)(q27;p21), with BCL6.
Protein Families
Histone H4 family
Subcellular Location
Nucleus. Chromosome.

Q&A

What is HIST1H4A and what role does it play in chromatin structure?

HIST1H4A belongs to the histone H4 family, which are basic nuclear proteins responsible for the nucleosome structure of chromosomal fiber in eukaryotes. Histones are fundamental components of chromatin, where two molecules of each core histone (H2A, H2B, H3, and H4) form an octamer around which approximately 146 bp of DNA wraps to create nucleosomes. HIST1H4A is intronless and is located within the large histone gene cluster on chromosome 6 . Unlike typical mRNA, transcripts from this gene lack polyA tails and instead contain a palindromic termination element . The protein plays a critical role in DNA packaging and chromosome condensation during cell division and influences gene expression through various post-translational modifications.

What applications is the HIST1H4A (Ab-79) antibody validated for?

The HIST1H4A (Ab-79) Polyclonal Antibody has been validated for multiple research applications that allow for diverse experimental approaches:

ApplicationDescriptionValidation Status
ELISAEnzyme-Linked Immunosorbent Assay for protein quantificationValidated
IHCImmunohistochemistry for tissue localization studiesValidated
ChIPChromatin Immunoprecipitation for DNA-protein interaction studiesValidated
WBWestern Blotting for protein identification and semi-quantificationValidated
IFImmunofluorescence for subcellular localizationValidated

When designing experiments, researchers should note that this antibody is specifically developed for human samples and cross-reactivity with other species should be verified before use in comparative studies .

What is the specificity and target site of the HIST1H4A (Ab-79) antibody?

The HIST1H4A (Ab-79) antibody is designed to recognize and bind to a peptide sequence around the site of Lysine 79 (Lys79) derived from Human Histone H4 . This specificity is important for researchers studying histone modifications in this region. The antibody has been developed using rabbits as the host organism and is of IgG isotype . The polyclonal nature of this antibody means it can recognize multiple epitopes of the target antigen, potentially increasing sensitivity but requiring careful validation of specificity.

For researchers interested in post-translational modifications, it's worth noting that other specialized antibodies such as those detecting formylation at K91 are also available for histone H4 research , suggesting that researchers should carefully select the appropriate antibody based on the specific modification site they are investigating.

How should samples be prepared for optimal detection using HIST1H4A (Ab-79) antibody?

For optimal results with the HIST1H4A (Ab-79) antibody, sample preparation protocols should be tailored to the specific application:

For Western Blotting:

  • Prepare cell lysates in a buffer containing protease inhibitors to prevent histone degradation

  • For histone-specific preparation, consider acid extraction methods that enrich for basic proteins

  • Load 15-25 μg of total protein per lane (based on NIH/3T3 cell lysate loading)

  • Use SDS-PAGE with appropriate percentage gels for low molecular weight proteins (the predicted band size for histone H4 is approximately 11 kDa)

For ELISA Applications:

  • Sample dilution should be carefully considered based on expected protein concentration

  • Linearity of dilution studies indicate that serum samples show good recovery (95-108% at 1:1 dilution)

  • Detection range for commercial ELISA kits is typically 37.5-2400 pg/mL with a sensitivity of 9.3 pg/mL

For Chromatin Immunoprecipitation:

  • Crosslink proteins to DNA using formaldehyde (typically 1% for 10 minutes)

  • Sonicate chromatin to appropriate fragment sizes (200-500 bp)

  • Use 2-5 μg of antibody per immunoprecipitation reaction

  • Include appropriate controls (input, IgG control, positive control target)

What controls should be included when working with HIST1H4A (Ab-79) antibody?

When designing experiments using the HIST1H4A (Ab-79) antibody, incorporating appropriate controls is essential for result interpretation and troubleshooting:

Positive Controls:

  • Known histone H4-expressing cell lines (most eukaryotic cells express histones)

  • Recombinant histone H4 protein

  • Previously validated sample with confirmed histone H4 expression

Negative Controls:

  • Secondary antibody only (no primary antibody) to assess background

  • Isotype control (rabbit IgG) to identify non-specific binding

  • Peptide competition assay using the immunizing peptide to confirm specificity

Application-Specific Controls:

  • For ChIP: Input chromatin (pre-immunoprecipitation sample)

  • For ELISA: Standard curve using recombinant HIST1H4A protein

  • For IHC/IF: Tissue known to be negative for the target or with primary antibody omitted

Validation Controls:

  • Histone H4 peptide array to confirm binding specificity to the target site (Lys79)

  • Western blot showing predicted molecular weight (11 kDa)

What protein interactions have been identified for HIST1H4A and how might they influence experimental design?

HIST1H4A has been shown to interact with multiple proteins that may impact chromatin structure and function. Researchers should consider these interactions when designing experiments and interpreting results:

Interacting ProteinDescriptionStandardized Interaction Value
RAB5CMember of RAS oncogene family, involved in endocytosis0.682774
ATP5BATP synthase subunit, mitochondrial F1 complex0.578784
RTFDC1Replication termination factor 2 domain containing 10.400252
XXYLT1Xyloside xylosyltransferase 10.400252
HS3ST3A1Heparan sulfate 3-O-sulfotransferase 3A10.400252
PFASPhosphoribosylformylglycinamidine synthase0.400252
HIST1H2BLHistone cluster 1, H2BL variant0.269638

These interactions suggest that HIST1H4A may be involved in diverse cellular processes beyond its structural role in chromatin. The strong interaction with RAB5C (standardized value: 0.682774) indicates potential involvement in membrane trafficking pathways, while interaction with ATP5B suggests possible links to cellular energetics .

When designing co-immunoprecipitation experiments or studying chromatin complexes, researchers should consider these interaction partners as potential confounding factors or additional targets for investigation.

What are the methodological considerations for using HIST1H4A (Ab-79) antibody in ChIP assays?

Chromatin Immunoprecipitation (ChIP) using HIST1H4A (Ab-79) antibody requires specific methodological considerations to optimize results:

Chromatin Preparation:

  • Crosslinking: Use 1% formaldehyde for 10 minutes at room temperature for most cell types

  • Sonication: Optimize sonication conditions to achieve DNA fragments of 200-500 bp

  • Chromatin quality: Verify fragmentation by agarose gel electrophoresis before proceeding

Immunoprecipitation Protocol:

  • Pre-clearing: Use protein A/G beads to reduce non-specific binding

  • Antibody amount: Use 2-5 μg of HIST1H4A (Ab-79) antibody per reaction

  • Incubation time: Overnight incubation at 4°C generally yields optimal results

  • Washing stringency: Use increasingly stringent wash buffers to reduce background

Data Analysis Considerations:

  • Normalization: Compare enrichment to input chromatin and IgG control

  • Positive control loci: Include primers for known histone H4-enriched genomic regions

  • Sequencing considerations: For ChIP-seq, ensure sufficient sequencing depth (>20 million reads)

How can researchers effectively study post-translational modifications of HIST1H4A?

Histone H4 undergoes numerous post-translational modifications (PTMs) that regulate chromatin structure and function. To effectively study these modifications:

Selection of Modification-Specific Antibodies:

  • For lysine 79 modifications: Use the HIST1H4A (Ab-79) antibody as it targets this region

  • For other modifications: Select antibodies specific to the modification of interest (e.g., formylation at K91)

  • Validate antibody specificity against peptide arrays containing modified and unmodified peptides

Experimental Approaches:

  • Western blotting: Use modification-specific antibodies alongside total H4 antibodies

  • Mass spectrometry: For unbiased identification of multiple PTMs simultaneously

  • ChIP-seq: Map genome-wide distribution of specific histone modifications

  • Sequential ChIP (Re-ChIP): Identify genomic regions containing multiple modifications

Quantification Methods:

  • ELISA assays: Provide quantitative measurement of specific modifications with sensitivity down to 9.3 pg/mL

  • Protein arrays: Allow multiplexed detection of multiple histone modifications

  • Imaging approaches: Visualize spatial distribution of modifications within nuclei

When studying histone modifications, it's crucial to consider the dynamic nature of these marks and their potential crosstalk. For example, modifications at one residue may influence the accessibility or recognition of nearby sites by modifying enzymes or antibodies.

What challenges might researchers encounter when using HIST1H4A (Ab-79) antibody in different experimental systems?

When working with HIST1H4A (Ab-79) antibody across different experimental systems, researchers should be aware of several potential challenges:

Cross-Reactivity Considerations:

  • Species specificity: The antibody is validated for human samples but may show variable cross-reactivity with other species

  • Histone variant recognition: Given the high sequence conservation among H4 variants, verify specificity against closely related proteins

  • Epitope masking: Post-translational modifications near Lys79 may affect antibody binding

Technical Challenges by Application:

  • Western Blotting:

    • Low molecular weight of histones (11 kDa) requires appropriate gel percentage

    • Histones are highly basic proteins that may need specialized transfer conditions

  • Immunohistochemistry:

    • Fixation methods significantly impact histone epitope accessibility

    • Nuclear localization requires careful permeabilization optimization

  • ELISA:

    • Matrix effects from different sample types may affect detection

    • Linear detection range in serum samples is 37.5-2400 pg/mL

Reproducibility Considerations:

  • Lot-to-lot variation: Polyclonal antibodies may show batch variation

  • Sample preparation consistency: Histone extraction methods should be standardized

  • Quantification challenges: ELISA kits show intra-assay precision (CV<8%) and inter-assay precision (CV<10%)

How can researchers integrate HIST1H4A studies with broader epigenetic research?

Integrating HIST1H4A research into broader epigenetic studies requires consideration of multiple molecular mechanisms and analytical approaches:

Multi-Omics Integration Strategies:

  • Combine ChIP-seq data using HIST1H4A (Ab-79) antibody with:

    • RNA-seq to correlate histone modifications with gene expression

    • ATAC-seq to assess chromatin accessibility

    • DNA methylation profiling to understand epigenetic crosstalk

Functional Analysis Approaches:

  • CRISPR-based histone modification: Target specific modifications at HIST1H4A

  • Histone demethylase/methyltransferase inhibitors: Assess impact on HIST1H4A modifications

  • Single-cell approaches: Investigate cell-to-cell variability in HIST1H4A modifications

Biological Context Considerations:

  • Cell cycle analysis: HIST1H4A modifications change during different cell cycle phases

  • Development and differentiation: Study dynamic changes during cellular differentiation

  • Disease models: Compare HIST1H4A modifications in normal vs. pathological states

Data Analysis Frameworks:

  • Enrichment analysis: Identify biological pathways associated with HIST1H4A-bound regions

  • Motif analysis: Determine transcription factors that co-localize with HIST1H4A modifications

  • Chromosome conformation data integration: Connect HIST1H4A modifications with 3D genome organization

When examining protein interactions, researchers should note that HIST1H4A interacts with diverse proteins including chromatin components (HIST1H2BL), metabolic enzymes (ATP5B, ATP5A1), and signaling molecules (RAB5C) , suggesting involvement in multiple cellular processes beyond chromatin structure.

What are common troubleshooting strategies for experiments using HIST1H4A (Ab-79) antibody?

When experiments with HIST1H4A (Ab-79) antibody don't yield expected results, consider these troubleshooting approaches:

For Weak or No Signal:

  • Antibody concentration: Titrate antibody to determine optimal concentration

  • Epitope accessibility: Modify fixation/permeabilization protocols to improve antigen retrieval

  • Sample preparation: Ensure histones are properly extracted and not degraded

  • Detection system: Verify secondary antibody functionality and consider signal amplification

For High Background:

  • Blocking optimization: Test different blocking reagents (BSA, milk, serum)

  • Washing stringency: Increase number and duration of wash steps

  • Antibody specificity: Perform peptide competition assay to verify specific binding

  • Sample quality: Reduce endogenous peroxidase activity or autofluorescence

For Unexpected Results:

  • Positive controls: Include known HIST1H4A-expressing samples

  • Band size verification: Confirm correct molecular weight (11 kDa for histone H4)

  • Lot testing: Compare results across different antibody lots

  • Protocol consistency: Standardize all steps of the experimental workflow

How should researchers validate the specificity and performance of HIST1H4A (Ab-79) antibody?

Comprehensive validation of HIST1H4A (Ab-79) antibody ensures reliable experimental outcomes:

Specificity Validation:

  • Peptide array testing: Verify binding to target peptide versus related sequences

  • Western blot: Confirm single band at expected molecular weight (11 kDa)

  • Knockdown/knockout controls: Reduced signal in HIST1H4A-depleted samples

  • Peptide competition: Pre-incubation with immunizing peptide should abolish signal

Performance Validation:

  • Sensitivity assessment: Determine lower limit of detection (ELISA sensitivity: 9.3 pg/mL)

  • Dynamic range: Verify linear detection range (ELISA range: 37.5-2400 pg/mL)

  • Reproducibility testing:

    • Intra-assay precision: CV<8% for repeated measurements within an assay

    • Inter-assay precision: CV<10% for measurements across different assays

Application-Specific Validation:

  • For IHC/IF: Staining pattern should match known nuclear localization

  • For ChIP: Enrichment at known histone H4-associated genomic regions

  • For ELISA: Recovery testing across sample types (serum recovery: 93%, range 89-97%)

How is HIST1H4A research contributing to understanding chromatin dynamics?

Research utilizing tools like the HIST1H4A (Ab-79) antibody is advancing our understanding of chromatin dynamics in several key areas:

Nucleosome Assembly and Stability:

  • HIST1H4A interactions with other histones, particularly HIST1H2BL (interaction value: 0.269638) , provide insights into nucleosome assembly mechanisms

  • Studies of HIST1H4A modifications help explain how chromatin structure changes during cell cycle progression

Regulatory Networks:

  • Interactions between HIST1H4A and non-histone proteins such as RAB5C (interaction value: 0.682774) suggest unexpected connections between chromatin and membrane trafficking pathways

  • HIST1H4A association with metabolic enzymes like ATP5B (interaction value: 0.578784) points to potential links between cellular energetics and chromatin structure

Technological Advances:

  • Antibodies targeting specific HIST1H4A modifications enable genome-wide mapping of epigenetic landscapes

  • Increasing specificity of tools like the HIST1H4A (Ab-79) antibody allows for more precise dissection of histone variant functions

What emerging applications might benefit from HIST1H4A (Ab-79) antibody research?

Several cutting-edge research areas could be advanced through applications of HIST1H4A (Ab-79) antibody:

Single-Cell Epigenomics:

  • Adaptation of ChIP protocols for single-cell analysis to study cell-to-cell variation in HIST1H4A modifications

  • Integration with single-cell transcriptomics to correlate histone modifications with gene expression heterogeneity

Liquid Biopsy Development:

  • Detection of circulating HIST1H4A in serum samples as potential biomarkers (ELISA sensitivity: 9.3 pg/mL)

  • Monitoring dynamic changes in histone modifications during disease progression

Therapeutic Target Validation:

  • Studying how experimental drugs affect HIST1H4A modifications and interactions

  • Identifying specific HIST1H4A modifications associated with disease states

Developmental Biology:

  • Mapping changes in HIST1H4A modifications during cellular differentiation

  • Understanding the role of specific histone variants in developmental programming

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.